Freestone Capital Holdings’s Pfizer PFE Stock Holding History

Freestone Capital Holdings’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.39M	Buy	49,665 +758	+2%	+$20.2K	0.04%	212
2025 Q4	$1.22M	Sell	48,907 -75,825	-61%	-$1.91M	0.04%	222
2025 Q3	$3.18M	Buy	124,732 +19,877	+19%	+$491K	0.1%	135
2025 Q2	$2.54M	Sell	104,855 -27,332	-21%	-$637K	0.09%	150
2025 Q1	$3.35M	Buy	132,187 +3,558	+3%	+$93.1K	0.12%	123
2024 Q4	$3.41M	Sell	128,629 -105,582	-45%	-$2.86M	0.12%	117
2024 Q3	$6.78M	Buy	234,211 +69,131	+42%	+$2.02M	0.23%	73
2024 Q2	$4.62M	Buy	165,080 +22,498	+16%	+$619K	0.17%	92
2024 Q1	$3.96M	Buy	142,582 +57,927	+68%	+$1.61M	0.15%	110
2023 Q4	$2.44M	Buy	84,655 +1,421	+2%	+$43K	0.11%	141
2023 Q3	$2.76M	Sell	83,234 -4,242	-5%	-$150K	0.15%	119
2023 Q2	$3.21M	Sell	87,476 -1,077	-1%	-$41.9K	0.13%	113
2023 Q1	$3.61M	Sell	88,553 -2,624	-3%	-$113K	0.16%	92
2022 Q4	$4.67M	Sell	91,177 -22,814	-20%	-$1.09M	0.21%	82
2022 Q3	$4.99M	Sell	113,991 -10,490	-8%	-$510K	0.23%	67
2022 Q2	$6.53M	Sell	124,481 -22,777	-15%	-$1.16M	0.25%	67
2022 Q1	$7.62M	Sell	147,258 -14,276	-9%	-$741K	0.31%	71
2021 Q4	$9.54M	Sell	161,534 -2,045	-1%	-$101K	0.4%	52
2021 Q3	$7.04M	Sell	163,579 -70,691	-30%	-$3.13M	0.35%	66
2021 Q2	$9.17M	Sell	234,270 -2,445	-1%	-$95.1K	0.46%	50
2021 Q1	$8.58M	Buy	236,715 +20,763	+10%	+$737K	0.47%	52
2020 Q4	$7.95M	Buy	215,952 +58,742	+37%	+$2.15M	0.46%	47
2020 Q3	$5.47M	Buy	157,210 +12,439	+9%	+$436K	0.36%	70
2020 Q2	$4.49K	Buy	144,771 +10,721	+8%	+$364K	0.05%	86
2020 Q1	$4.15K	Buy	134,050 +35,088	+35%	+$1.2M	0.09%	80
2019 Q4	$3.68K	Buy	98,962 +31,768	+47%	+$1.13M	0.08%	119
2019 Q3	$2.29K	Buy	67,194 +12,960	+24%	+$471K	0.06%	163
2019 Q2	$2.23K	Sell	54,234 -216	-0.4%	-$8.58K	0.06%	150
2019 Q1	$2.19M	Buy	54,450 +5,305	+11%	+$212K	0.13%	157
2018 Q4	$2.04M	Sell	49,145 -115,291	-70%	-$4.79M	0.14%	160
2018 Q3	$6.88M	Sell	164,436 -10,939	-6%	-$421K	0.04%	72
2018 Q2	$6.04M	Buy	175,375 +7,049	+4%	+$241K	0.04%	94
2018 Q1	$5.67M	Buy	168,326 +10,227	+6%	+$352K	0.33%	82
2017 Q4	$5.43M	Buy	158,099 +8,561	+6%	+$292K	0.38%	73
2017 Q3	$5.07M	Buy	149,538 +29,325	+24%	+$942K	0.36%	77
2017 Q2	$3.83M	Buy	120,213 +6,541	+6%	+$206K	0.3%	89
2017 Q1	$3.69M	Buy	113,672 +15,344	+16%	+$484K	0.28%	78
2016 Q4	$3.03M	Buy	98,328 +11,214	+13%	+$342K	0.26%	85
2016 Q3	$2.8M	Buy	87,114 +11,237	+15%	+$376K	0.26%	80
2016 Q2	$2.54M	Buy	75,877 +54,171	+250%	+$1.73M	0.25%	76
2016 Q1	$610K	Sell	21,706 -27,902	-56%	-$797K	0.06%	230
2015 Q4	$1.52M	Buy	49,608 +12,387	+33%	+$390K	0.16%	98
2015 Q3	$1.11M	Buy	37,221 +25,939	+230%	+$832K	0.12%	137
2015 Q2	$359K	Buy	+11,282	New	+$368K	0.06%	188
2014 Q3	–	Sell	-7,428	Closed	-$209K	–	167
2014 Q2	$209K	Buy	+7,428	New	+$212K	0.03%	186
2014 Q1	–	Sell	-7,164	Closed	-$208K	–	277
2013 Q4	$208K	Sell	7,164 -31,689	-82%	-$922K	0.04%	262
2013 Q3	$933K	Buy	+38,853	New	+$1.06M	0.17%	132

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Freestone Capital Holdings's PFE Position: Q1 2026 in Review

Freestone Capital Holdings increased its Pfizer (PFE) stake by 1.5% in Q1 2026, buying an estimated $20.2K and bringing the position to 49,665 shares worth $1.39M. The position accounts for 0.04% of the portfolio, ranked #212.

Freestone Capital Holdings first reported a position in PFE in Q3 2013 and has held it in 47 quarters since. The position peaked at $9.54M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Freestone Capital Holdings held 49,665 shares of Pfizer worth $1.39M as of Q1 2026.
Freestone Capital Holdings bought 758 Pfizer shares in Q1 2026, an estimated $20.2K.
Pfizer made up 0.04% of Freestone Capital Holdings's portfolio in Q1 2026, its #212 holding.
Freestone Capital Holdings first reported a position in Pfizer in Q3 2013 and has held it in 47 quarters since.
Freestone Capital Holdings's Pfizer position peaked at $9.54M in Q4 2021.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.